KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Inventory Average (2016 - 2025)

Historic Inventory Average for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $11.6 billion.

  • Pfizer's Inventory Average fell 13.38% to $11.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year decrease of 13.38%. This contributed to the annual value of $11.3 billion for FY2024, which is N/A changed from last year.
  • Pfizer's Inventory Average amounted to $11.6 billion in Q3 2025, which was down 13.38% from $11.3 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Inventory Average ranged from a high of $11.6 billion in Q3 2024 and a low of $8.3 billion during Q2 2021
  • Moreover, its 5-year median value for Inventory Average was $10.2 billion (2023), whereas its average is $10.1 billion.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 1715.5% in 2022, then crashed by 284.83% in 2023.
  • Quarter analysis of 5 years shows Pfizer's Inventory Average stood at $8.8 billion in 2021, then rose by 4.49% to $9.2 billion in 2022, then increased by 10.27% to $10.2 billion in 2023, then increased by 10.69% to $11.3 billion in 2024, then increased by 2.5% to $11.6 billion in 2025.
  • Its Inventory Average was $11.6 billion in Q3 2025, compared to $11.3 billion in Q2 2025 and $10.9 billion in Q1 2025.